These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5596798)

  • 41. [Treatment of infectious-toxic and traumatic lesion, of the hypothalamic region with aminalon and gammalon].
    Poemnyĭ FA; Trubnikov BM
    Klin Med (Mosk); 1975 Sep; 53(9):52-5. PubMed ID: 1232498
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of phenelzine and aminoxyacetic acid on gamma-aminobutyric acid, glutamic acid decarboxylase and gamma-aminobutyric acid-ketoglutaric acid transaminase in various regions of the rat brain].
    Popov N; Pohle W; Matthies H
    Acta Biol Med Ger; 1968; 20(4):509-16. PubMed ID: 5696139
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effects of lithium hydroxybutyrate and vagotomy on respiratory arrest caused by systemic serotonin administration in rats].
    Tarakanov IA; Tarasiva NN; Safronov VA
    Eksp Klin Farmakol; 2005; 68(6):30-5. PubMed ID: 16405031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [On the role of gamma aminobutyric acid in the regulation of the level of glycemia in diabetes mellitus].
    Khumarian NG; Mamikonian RS
    Zh Eksp Klin Med; 1967; 7(2):3-9. PubMed ID: 5605571
    [No Abstract]   [Full Text] [Related]  

  • 45. [Gamma- and amino-butyric acids and gamma-amino-beta-hydroxy-butyric acid as pharmacoprotective agents in experimental hyperoxic neuro-intoxication].
    Moretti G; Fontanesi S
    Ann Med Nav (Roma); 1966; 71(6):783-92. PubMed ID: 5999266
    [No Abstract]   [Full Text] [Related]  

  • 46. [The evaluation of the effects of piracetam and N-acetylaspartic acid on memory and the content of mediator amino acids in the brain in a model neurotic state in rats].
    Raevskiĭ KS; Nerush PA
    Biull Eksp Biol Med; 1993 Nov; 116(11):511-3. PubMed ID: 8312544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical pharmacology of aggressive behavior.
    Sheard MH
    Clin Neuropharmacol; 1984; 7(3):173-83. PubMed ID: 6149018
    [No Abstract]   [Full Text] [Related]  

  • 48. Synthesis of derivatives of beta-aminomethyl-gamma-(p-chlorophenyl)-gamma-hydroxybutyric acid.
    Jakóbiec T; Zabska R; Zawisza T
    Pol J Pharmacol Pharm; 1982; 34(4):239-46. PubMed ID: 7182845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Observations on the clinical use of GABOB (gamma-amino-beta-hydroxybutyric acid). Administration of the drug by intravenous route. (Preliminary observations)].
    GORI EC
    G Psichiatr Neuropatol; 1962; 90():853-60. PubMed ID: 13949277
    [No Abstract]   [Full Text] [Related]  

  • 50. [Active transport of amino acids in sliced brain tissue specimens in guinea pigs. Regional differences in the amount of gamma aminobutyric acid uptake].
    Nakamura R; Nagayama M; Akimoto H
    Shinkei Kenkyu No Shimpo; 1965 Sep; 9(3):541-7. PubMed ID: 5894768
    [No Abstract]   [Full Text] [Related]  

  • 51. [gamma-Aminobutyric acid (GABA) and gamma-amino-beta-hydroxybutyric acid (GABOB) in the perspective of biological anti-epilepsy therapy].
    DE MAIO D; MADEDDU A; FAGGIOLI L
    Acta Neurol (Napoli); 1961; 16():366-406. PubMed ID: 13720682
    [No Abstract]   [Full Text] [Related]  

  • 52. Vigabatrin improves paroxysmal dystonia in succinic semialdehyde dehydrogenase deficiency.
    Leuzzi V; Di Sabato ML; Deodato F; Rizzo C; Boenzi S; Carducci C; Malaspina P; Liberanome C; Dionisi-Vici C
    Neurology; 2007 Apr; 68(16):1320-1. PubMed ID: 17438226
    [No Abstract]   [Full Text] [Related]  

  • 53. GABOB (gamma-amino-beta-hydroxybutyric acid) treatment in epilepsy.
    WADA T; GOTO A; FUKUSHIMA Y; TATEYAMA K
    Folia Psychiatr Neurol Jpn; 1961 Dec; 15():327-35. PubMed ID: 13998150
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical data on a combination of gamma-aminobutyric acid with an androgen, in psycho-neuro-endocrine disorders].
    de Moraes JB; Dias MS
    Hospital (Rio J); 1965 Aug; 68(2):467-71. PubMed ID: 5295133
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of periodic disturbance of consciousness in the specific type of hepatocerebral degeneration (inose type) a trial with Gobab.
    Takahashi T; Miyakoshi T; Wada T
    Int J Neurol; 1972; 9(1):43-53. PubMed ID: 5086637
    [No Abstract]   [Full Text] [Related]  

  • 56. [Gamma-hydroxybutyric acid anesthesia--its application to oral surgery].
    Kokita Y; Nakakuki T; Susa A; Yamaguchi T; Tayama S
    Shikwa Gakuho; 1968 Feb; 68(2):255-61. PubMed ID: 5245933
    [No Abstract]   [Full Text] [Related]  

  • 57. [A study of 2-dimethylaminoethanol (DMAE) in various forms of psychoneurosis].
    Pugliese L; Papeschi R
    Riv Neurobiol; 1966; 12(2):251-63. PubMed ID: 5335605
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical experience on the use of a new psychostimulant drug: phenyl pyrrolidinopentane. Clinicotherapeutic findigs].
    Devoto TS; Badano CF; Ceias de Scaglia MA
    Prensa Med Argent; 1970 Apr; 57(5):263-6. PubMed ID: 5453414
    [No Abstract]   [Full Text] [Related]  

  • 59. [New aspects of seizure therapy].
    Wiechert P
    Dtsch Gesundheitsw; 1970 Sep; 25(37):1748-50. PubMed ID: 5487494
    [No Abstract]   [Full Text] [Related]  

  • 60. [Preliminary results of the use of gamma-hydroxybutyric acid in parkinsonian syndromes].
    Greggia A; Casalgrandi L; Boncinelli A; Prandi G
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Apr; 95(2):412-9. PubMed ID: 5091480
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.